1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Glucagon-Like Peptide-1 Receptor Agonists: new trials by email Literature Review of Glucagon-Like Peptide-1 Receptor Agonists trials Research Report on Glucagon-Like Peptide-1 Receptor Agonists
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms Semaglutide 1.0 mg, Semaglutide 0.5 mg - Glucagon-Like Peptide-1 Receptor Agonists, Type 2 Diabetes | Phase 4 | Not yet recruiting | Taipei Veterans General Hospital, Taiwan | 60 | 2025-10-01 | 2025-07-18 |
Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
semaglutide (1)
Taipei Veterans General Hospital, Taiwan (1)
Taiwan (1)